PEP Therapy – innovative peptides as targeted therapies for oncology

PEP Therapy is a biotech company developing targeted therapies for the treatment of severe diseases, with an initial focus on cancer.

PEP Therapy – innovative peptides as targeted therapies for oncology

PEP Therapy Continue reading

Cellectis – gene-editing

Cellectis is a biotech company focused on developing immunotherapies based on gene edited engineered CAR-T cells (UCART).

Cellectis – gene-editing

Cellectis

Continue reading